Jafar Aljazeeri, MD, an assistant professor in Drexel’s College of Medicine, was senior author on a recently published systematic review and meta-analysis in the journal Sleep and Breathing that looked at six randomized controlled trials of 1,069 OSA patients taking the GLP-1 liraglutide or tirzepatide.
